Biotech company revolutionizing the treatment of nerve damage. Creating innovative treatments for nervous system damage due to injury or disease
Search results
Fell 31%
- Shares of Heron Therapeutics Inc. fell 31% on Wednesday after the biotech said the FDA would not approve the new drug application for its pain-management drug HTX-011 in its present form.
People also ask
Does Heron Therapeutics Inc (hrtx) pay a dividend?
Where is Heron Therapeutics Inc headquartered?
What is the 12-month price forecast for heron Therapeutics (hrtx)?
Should you buy Heron Therapeutics (hrtx) in 2023?
Should you buy hrtx (hrtx) stock?
Is Heron Therapeutics a good stock to buy?
Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Profile
See the company profile for Heron Therapeutics, Inc. (HRTX)...
- Options
View the basic HRTX option chain and compare options of...
- Financials
Get the detailed quarterly/annual income statement for Heron...
- Conversations
Find the latest Heron Therapeutics, Inc. (HRTX) stock...
- Holders
Holder Shares Date Reported % Out Value; Vanguard Total...
- Analysis
See Heron Therapeutics, Inc. (HRTX) stock analyst estimates,...
- Statistics
Find out all the key statistics for Heron Therapeutics, Inc....
- Historical Data
Discover historical prices for HRTX stock on Yahoo Finance....
- Profile
Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.
- 274.52M
- 136.36M
- 48.13M
- 151.67M
4 days ago · Should You Buy or Sell Heron Therapeutics Stock? Get The Latest HRTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (858) 251-4400
- 4242 CAMPUS POINT COURT SUITE 200, SAN DIEGO CA, 92121
- ir@herontx.com
Get the latest Heron Therapeutics Inc (HRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
4 days ago · Over the past 5 years, Heron Therapeutics, Inc.’s stock price has decreased by 91.60%. Heron Therapeutics, Inc.’s stock price is currently approximately $1.77.
2 days ago · Shares of Heron Therapeutics Inc. fell 31% on Wednesday after the biotech said the FDA would not approve the new drug application for its pain-management drug HTX-011 in its present form.
View the latest Heron Therapeutics Inc. (HRTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.